KPNβ1 promotes palmitate-induced insulin resistance via NF-κB signaling in hepatocytes

被引:16
作者
Wang, Suxin [1 ]
Zhao, Yun [1 ]
Xia, Nana [1 ]
Zhang, Wanlu [1 ]
Tang, Zhuqi [1 ]
Wang, Cuifang [1 ]
Zhu, Xiaohui [1 ]
Cui, Shiwei [1 ]
机构
[1] Affiliated Hosp Nantong Univ, Dept Endocrinol & Metab Dis, Nantong 226001, Peoples R China
关键词
KPN beta 1; Inflammation; Insulin resistance; NF-kappa B; INFLAMMATORY MECHANISMS; NUCLEAR IMPORT; FATTY-ACIDS; OBESITY; GLUCOSE; INHIBITION; PATHOGENESIS; ACTIVATION; PATHWAYS; STRESS;
D O I
10.1007/s13105-015-0440-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been intensively studied that inflammation contributes to the insulin resistance development in obesity-induced type 2 diabetes mellitus (T2DM). In this study, we assessed the effect of karyopherin beta 1 (KPN beta 1) in hepatic insulin resistance and the underlying mechanisms using high-fat diet (HFD) fed mice and palmitate (PA)-stimulated hepatocytes (HepG2). KPN beta 1 expression is increased in the HFD fed mice liver. PA upregulated KPN beta 1 expression in HepG2 cells in a time-dependent manner. PA also increased pro-inflammatory cytokines expression, including tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), and interleukin 1 beta (IL-1 beta). KPN beta 1 knockdown reversed PA-induced pro-inflammatory cytokines expression and insulin-stimulated glucose uptake in HepG2 cells. In addition, KPN beta 1 knockdown reduced intracellular lipid accumulation. Mechanistically, KPN beta 1 transports nuclear factor kB (NF-kappa B) p65 from the cytoplasm to the nucleus to increase pro-inflammatory genes expression. In summary, KPN beta 1 acts as a positive regulator in the NF-kappa B pathway to enhance palmitate-induced inflammation response and insulin resistance in HepG2 cells.
引用
收藏
页码:763 / 772
页数:10
相关论文
共 35 条
[1]  
Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4
[2]   OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls [J].
Baud, Veronique ;
Karin, Michael .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) :33-40
[3]   From mice to men: Insights into the insulin resistance syndromes [J].
Biddinger, SB ;
Kahn, CR .
ANNUAL REVIEW OF PHYSIOLOGY, 2006, 68 :123-158
[4]   Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].
Boden, G .
DIABETES, 1997, 46 (01) :3-10
[5]   Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction [J].
Boden, G ;
Shulman, GI .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 :14-23
[6]   Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic β-cell line INS-1 [J].
Cousin, SP ;
Hügl, SR ;
Wrede, CE ;
Kajio, H ;
Myers, MG ;
Rhodes, CJ .
ENDOCRINOLOGY, 2001, 142 (01) :229-240
[7]   Metabolic syndrome - A comprehensive perspective based on interactions between obesity, diabetes, and inflammation [J].
Dandona, P ;
Aljada, A ;
Chaudhuri, A ;
Mohanty, P ;
Garg, R .
CIRCULATION, 2005, 111 (11) :1448-1454
[8]   Type 2 diabetes as an inflammatory disease [J].
Donath, Marc Y. ;
Shoelson, Steven E. .
NATURE REVIEWS IMMUNOLOGY, 2011, 11 (02) :98-107
[9]   The Effects of Palmitate on Hepatic Insulin Resistance Are Mediated by NADPH Oxidase 3-derived Reactive Oxygen Species through JNK and p38MAPK Pathways [J].
Gao, Dan ;
Nong, Shanwei ;
Huang, Xiuqing ;
Lu, Yonggang ;
Zhao, Hongye ;
Lin, Yajun ;
Man, Yong ;
Wang, Shu ;
Yang, Jiefu ;
Li, Jian .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (39) :29965-29973
[10]   NF-κB as a Target for Modulating Inflammatory Responses [J].
Gasparini, Chiara ;
Feldmann, Marc .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (35) :5735-5745